NCT00113984View on ClinicalTrials.gov

Vaccine and Antibody Treatment of Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 8, 2005

Primary Completion Date

February 1, 2008

Study Completion Date

December 1, 2011

Conditions
Prostatic Neoplasms
Interventions
BIOLOGICAL

PROSTVAC-V/TRICOM

BIOLOGICAL

PROSTVAC-F/TRICOM

DRUG

MDX-010

DRUG

Sargramostim

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00113984 - Vaccine and Antibody Treatment of Prostate Cancer | Biotech Hunter | Biotech Hunter